{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:12:01Z","timestamp":1790190721772,"version":"4.1.0"},"reference-count":162,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ncl.2018.01.004","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T22:14:52Z","timestamp":1523484892000},"page":"293-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies"],"prefix":"10.1016","volume":"36","author":[{"given":"Michael H.","family":"Rivner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamatha","family":"Pasnoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazen M.","family":"Dimachkie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Barohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ncl.2018.01.004_bib1","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","article-title":"Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value","volume":"26","author":"Lindstrom","year":"1976","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ncl.2018.01.004_bib2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0960-8966(96)00009-0","article-title":"Clinical heterogeneity of seronegative myasthenia gravis","volume":"6","author":"Evoli","year":"1996","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.1016\/j.ncl.2018.01.004_bib3","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0022-510X(91)90067-H","article-title":"Seronegative myasthenia gravis: clinical features, response to therapy and synthesis of acetylcholine receptor antibodies in\u00a0vitro","volume":"102","author":"Birmanns","year":"1991","journal-title":"J\u00a0Neurol Sci"},{"issue":"8473","key":"10.1016\/j.ncl.2018.01.004_bib4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0140-6736(86)92259-2","article-title":"Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity","volume":"1","author":"Mossman","year":"1986","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ncl.2018.01.004_bib5","first-page":"651","article-title":"Seronegative transient neonatal myasthenia: report of a case","volume":"45","author":"Oteiza Orradre","year":"1996","journal-title":"An Esp Pediatr"},{"issue":"9","key":"10.1016\/j.ncl.2018.01.004_bib6","first-page":"938","article-title":"Seronegative neonatal myasthenia gravis in one of the twins","volume":"41","author":"Sisman","year":"2004","journal-title":"Indian Pediatr"},{"issue":"1","key":"10.1016\/j.ncl.2018.01.004_bib7","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1055\/s-0036-1579624","article-title":"Seronegative maternal ocular myasthenia gravis and delayed transient neonatal myasthenia gravis","volume":"6","author":"Townsel","year":"2016","journal-title":"AJP Rep"},{"issue":"4","key":"10.1016\/j.ncl.2018.01.004_bib8","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/1531-8249(200004)47:4<504::AID-ANA14>3.0.CO;2-Q","article-title":"IgG from \u201cseronegative\u201d myasthenia gravis patients binds to a muscle cell line, TE671, but not to human acetylcholine receptor","volume":"47","author":"Blaes","year":"2000","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.ncl.2018.01.004_bib9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.ncl.2018.01.004_bib10","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis","volume":"69","author":"Higuchi","year":"2011","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.ncl.2018.01.004_bib11","first-page":"427","article-title":"Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis","volume":"259","author":"Pevzner","year":"2012","journal-title":"J\u00a0Neurol"},{"issue":"4","key":"10.1016\/j.ncl.2018.01.004_bib12","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archneurol.2011.2393","article-title":"Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis","volume":"69","author":"Zhang","year":"2012","journal-title":"Arch Neurol"},{"issue":"22","key":"10.1016\/j.ncl.2018.01.004_bib13","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1212\/WNL.0000000000000478","article-title":"Anti-agrin autoantibodies in myasthenia gravis","volume":"82","author":"Gasperi","year":"2014","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ncl.2018.01.004_bib14","doi-asserted-by":"crossref","first-page":"e91816","DOI":"10.1371\/journal.pone.0091816","article-title":"Autoantibodies to agrin in myasthenia gravis patients","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ncl.2018.01.004_bib15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jneuroim.2016.01.018","article-title":"Titin antibodies in \u201cseronegative\u201d myasthenia gravis\u2013a new role for an old antigen","volume":"292","author":"Stergiou","year":"2016","journal-title":"J\u00a0Neuroimmunol"},{"issue":"6","key":"10.1016\/j.ncl.2018.01.004_bib16","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/archneur.58.6.885","article-title":"Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients","volume":"58","author":"Yamamoto","year":"2001","journal-title":"Arch Neurol"},{"issue":"10","key":"10.1016\/j.ncl.2018.01.004_bib17","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.autrev.2014.08.039","article-title":"Cortactin autoantibodies in myasthenia gravis","volume":"13","author":"Gallardo","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ncl.2018.01.004_bib18","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1749-6632.1998.tb10972.x","article-title":"Rapsyn antibodies in myasthenia gravis","volume":"841","author":"Agius","year":"1998","journal-title":"Ann N Y Acad Sci"},{"issue":"23","key":"10.1016\/j.ncl.2018.01.004_bib19","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1093\/hmg\/ddr396","article-title":"A\u00a0valid mouse model of AGRIN-associated congenital myasthenic syndrome","volume":"20","author":"Bogdanik","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.ncl.2018.01.004_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ajhg.2009.06.015","article-title":"Identification of an agrin mutation that causes congenital myasthenia and affects synapse function","volume":"85","author":"Huze","year":"2009","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.ncl.2018.01.004_bib21","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1212\/01.WNL.0000085865.55513.AE","article-title":"Rapsyn mutations in hereditary myasthenia: distinct early- and late-onset phenotypes","volume":"61","author":"Burke","year":"2003","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ncl.2018.01.004_bib22","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s10038-003-0005-7","article-title":"Identification of pathogenic mutations in the human rapsyn gene","volume":"48","author":"Dunne","year":"2003","journal-title":"J\u00a0Hum Genet"},{"issue":"4","key":"10.1016\/j.ncl.2018.01.004_bib23","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1055\/s-2004-820993","article-title":"Congenital myasthenic syndrome due to rapsyn deficiency: three cases with arthrogryposis and bulbar symptoms","volume":"35","author":"Ioos","year":"2004","journal-title":"Neuropediatrics"},{"issue":"1","key":"10.1016\/j.ncl.2018.01.004_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1399-0004.2007.00824.x","article-title":"Congenital myasthenic syndrome caused by two non-N88K rapsyn mutations","volume":"72","author":"Maselli","year":"2007","journal-title":"Clin Genet"},{"issue":"3","key":"10.1016\/j.ncl.2018.01.004_bib25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/mus.10433","article-title":"Rapsyn mutations in myasthenic syndrome due to impaired receptor clustering","volume":"28","author":"Maselli","year":"2003","journal-title":"Muscle Nerve"},{"issue":"11","key":"10.1016\/j.ncl.2018.01.004_bib26","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1212\/01.WNL.0000072262.14931.80","article-title":"Rapsyn N88K is a frequent cause of congenital myasthenic syndromes in European patients","volume":"60","author":"Muller","year":"2003","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ncl.2018.01.004_bib27","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1086\/339465","article-title":"Rapsyn mutations in humans cause endplate acetylcholine-receptor deficiency and myasthenic syndrome","volume":"70","author":"Ohno","year":"2002","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.ncl.2018.01.004_bib28","doi-asserted-by":"crossref","first-page":"e53826","DOI":"10.1371\/journal.pone.0053826","article-title":"A\u00a0mutation causes MuSK reduced sensitivity to agrin and congenital myasthenia","volume":"8","author":"Ben Ammar","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ncl.2018.01.004_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clineuro.2016.08.021","article-title":"Limb-girdle congenital myasthenic syndrome in a Chinese family with novel mutations in MUSK gene and literature review","volume":"150","author":"Luan","year":"2016","journal-title":"Clin Neurol Neurosurg"},{"issue":"12","key":"10.1016\/j.ncl.2018.01.004_bib30","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1093\/hmg\/ddq110","article-title":"Mutations in MUSK causing congenital myasthenic syndrome impair MuSK-Dok-7 interaction","volume":"19","author":"Maselli","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"8","key":"10.1016\/j.ncl.2018.01.004_bib31","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/jamaneurol.2015.0853","article-title":"Impaired synaptic development, maintenance, and neuromuscular transmission in LRP4-related myasthenia","volume":"72","author":"Selcen","year":"2015","journal-title":"JAMA Neurol"},{"issue":"7","key":"10.1016\/j.ncl.2018.01.004_bib32","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00439-011-1132-4","article-title":"LG2 agrin mutation causing severe congenital myasthenic syndrome mimics functional characteristics of non-neural (z-) agrin","volume":"131","author":"Maselli","year":"2012","journal-title":"Hum Genet"},{"issue":"Pt 9","key":"10.1016\/j.ncl.2018.01.004_bib33","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1093\/brain\/awu160","article-title":"Agrin mutations lead to a congenital myasthenic syndrome with distal muscle weakness and atrophy","volume":"137","author":"Nicole","year":"2014","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.ncl.2018.01.004_bib34","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/hmg\/ddt578","article-title":"LRP4 third beta-propeller domain mutations cause novel congenital myasthenia by compromising agrin-mediated MuSK signaling in a position-specific manner","volume":"23","author":"Ohkawara","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"7","key":"10.1016\/j.ncl.2018.01.004_bib35","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1074\/jbc.270.7.3392","article-title":"Agrin is a heparan sulfate proteoglycan","volume":"270","author":"Tsen","year":"1995","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"10.1016\/j.ncl.2018.01.004_bib36","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.cell.2008.10.002","article-title":"Lrp4 is a receptor for Agrin and forms a complex with MuSK","volume":"135","author":"Kim","year":"2008","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ncl.2018.01.004_bib37","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.neuron.2008.10.006","article-title":"LRP4 serves as a coreceptor of agrin","volume":"60","author":"Zhang","year":"2008","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.ncl.2018.01.004_bib38","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.mcn.2004.09.013","article-title":"Motor neurite outgrowth is selectively inhibited by cell surface MuSK and Agrin","volume":"28","author":"Dimitropoulou","year":"2005","journal-title":"Mol Cell Neurosci"},{"issue":"4","key":"10.1016\/j.ncl.2018.01.004_bib39","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1083\/jcb.200307164","article-title":"MuSK is required for anchoring acetylcholinesterase at the neuromuscular junction","volume":"165","author":"Cartaud","year":"2004","journal-title":"J\u00a0Cell Biol"},{"issue":"1","key":"10.1016\/j.ncl.2018.01.004_bib40","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.cbi.2012.10.006","article-title":"Developmental consequences of the ColQ\/MuSK interactions","volume":"203","author":"Karmouch","year":"2013","journal-title":"Chem Biol Interact"},{"issue":"7","key":"10.1016\/j.ncl.2018.01.004_bib41","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/humu.22325","article-title":"Mutations in the C-terminal domain of ColQ in endplate acetylcholinesterase deficiency compromise ColQ-MuSK interaction","volume":"34","author":"Nakata","year":"2013","journal-title":"Hum Mutat"},{"issue":"3","key":"10.1016\/j.ncl.2018.01.004_bib42","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1101\/gad.180885.111","article-title":"Structural basis of agrin-LRP4-MuSK signaling","volume":"26","author":"Zong","year":"2012","journal-title":"Genes Dev"},{"issue":"1","key":"10.1016\/j.ncl.2018.01.004_bib43","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.molcel.2010.06.007","article-title":"The cytoplasmic adaptor protein Dok7 activates the receptor tyrosine kinase MuSK via dimerization","volume":"39","author":"Bergamin","year":"2010","journal-title":"Mol Cell"},{"issue":"3","key":"10.1016\/j.ncl.2018.01.004_bib44","first-page":"269","article-title":"The carboxyl-terminal region of Dok-7 plays a key, but not essential, role in activation of muscle-specific receptor kinase MuSK and neuromuscular synapse formation","volume":"161","author":"Ueta","year":"2017","journal-title":"J\u00a0Biochem"},{"issue":"59","key":"10.1016\/j.ncl.2018.01.004_bib45","doi-asserted-by":"crossref","first-page":"ra7","DOI":"10.1126\/scisignal.2000113","article-title":"Dok-7 activates the muscle receptor kinase MuSK and shapes synapse formation","volume":"2","author":"Inoue","year":"2009","journal-title":"Sci Signal"},{"key":"10.1016\/j.ncl.2018.01.004_bib46","first-page":"25","article-title":"Dok-7\/MuSK signaling and a congenital myasthenic syndrome","volume":"27","author":"Yamanashi","year":"2008","journal-title":"Acta Myol"},{"issue":"1","key":"10.1016\/j.ncl.2018.01.004_bib47","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neuroscience.2006.03.035","article-title":"The tetratricopeptide repeat domains of rapsyn bind directly to cytoplasmic sequences of the muscle-specific kinase","volume":"141","author":"Antolik","year":"2006","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.ncl.2018.01.004_bib48","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0896-6273(00)80303-7","article-title":"Rapsyn is required for MuSK signaling and recruits synaptic components to a MuSK-containing scaffold","volume":"18","author":"Apel","year":"1997","journal-title":"Neuron"},{"issue":"30","key":"10.1016\/j.ncl.2018.01.004_bib49","doi-asserted-by":"crossref","first-page":"15602","DOI":"10.1016\/S0021-9258(19)37631-8","article-title":"Identification of the mouse muscle 43,000-dalton acetylcholine receptor-associated protein (RAPsyn) by cDNA cloning","volume":"263","author":"Frail","year":"1988","journal-title":"J\u00a0Biol Chem"},{"issue":"6546","key":"10.1016\/j.ncl.2018.01.004_bib50","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/377232a0","article-title":"Failure of postsynaptic specialization to develop at neuromuscular junctions of rapsyn-deficient mice","volume":"377","author":"Gautam","year":"1995","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ncl.2018.01.004_bib51","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.neuroscience.2009.05.057","article-title":"Rapsyn interacts with the muscle acetylcholine receptor via alpha-helical domains in the alpha, beta, and epsilon subunit intracellular loops","volume":"163","author":"Lee","year":"2009","journal-title":"Neuroscience"},{"issue":"26","key":"10.1016\/j.ncl.2018.01.004_bib52","doi-asserted-by":"crossref","first-page":"10622","DOI":"10.1073\/pnas.1301277110","article-title":"Structure and superorganization of acetylcholine receptor-rapsyn complexes","volume":"110","author":"Zuber","year":"2013","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"3 Pt 2","key":"10.1016\/j.ncl.2018.01.004_bib53","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0092-8674(83)90101-0","article-title":"Crosslinking of proteins in acetylcholine receptor-rich membranes: association between the beta-subunit and the 43 kd subsynaptic protein","volume":"35","author":"Burden","year":"1983","journal-title":"Cell"},{"issue":"27","key":"10.1016\/j.ncl.2018.01.004_bib54","doi-asserted-by":"crossref","first-page":"24911","DOI":"10.1074\/jbc.M103258200","article-title":"Interactions of the rapsyn RING-H2 domain with dystroglycan","volume":"276","author":"Bartoli","year":"2001","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"10.1016\/j.ncl.2018.01.004_bib55","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0896-6273(95)90146-9","article-title":"Receptor tyrosine kinase specific for the skeletal muscle lineage: expression in embryonic muscle, at the neuromuscular junction, and after injury","volume":"15","author":"Valenzuela","year":"1995","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.ncl.2018.01.004_bib56","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0092-8674(00)81251-9","article-title":"The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in\u00a0vivo","volume":"85","author":"DeChiara","year":"1996","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.ncl.2018.01.004_bib57","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0092-8674(00)81252-0","article-title":"Agrin acts via a MuSK receptor complex","volume":"85","author":"Glass","year":"1996","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ncl.2018.01.004_bib58","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/ana.21371","article-title":"Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction","volume":"63","author":"Cole","year":"2008","journal-title":"Ann Neurol"},{"issue":"1\u20132","key":"10.1016\/j.ncl.2018.01.004_bib59","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jneuroim.2006.03.016","article-title":"Myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (MuSK)","volume":"175","author":"Jha","year":"2006","journal-title":"J\u00a0Neuroimmunol"},{"issue":"1\u20132","key":"10.1016\/j.ncl.2018.01.004_bib60","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jneuroim.2005.08.016","article-title":"MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in\u00a0vivo","volume":"170","author":"Benveniste","year":"2005","journal-title":"J\u00a0Neuroimmunol"},{"issue":"3","key":"10.1016\/j.ncl.2018.01.004_bib61","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jocn.2005.04.028","article-title":"MuSK antibody-positive, seronegative myasthenia gravis in Korea","volume":"13","author":"Lee","year":"2006","journal-title":"J\u00a0Clin Neurosci"},{"issue":"5","key":"10.1016\/j.ncl.2018.01.004_bib62","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/mus.20854","article-title":"Frequency of seronegativity in adult-acquired generalized myasthenia gravis","volume":"36","author":"Chan","year":"2007","journal-title":"Muscle Nerve"},{"issue":"12","key":"10.1016\/j.ncl.2018.01.004_bib63","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1212\/01.WNL.0000065882.63904.53","article-title":"Clinical aspects of MuSK antibody positive seronegative MG","volume":"60","author":"Sanders","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2018.01.004_bib64","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.ncl.2018.01.004_bib65","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1468-1331.2006.01214.x","article-title":"Seronegative myasthenia gravis: comparison of neurophysiological picture in MuSK+ and MuSK-patients","volume":"13","author":"Padua","year":"2006","journal-title":"Eur J Neurol"},{"issue":"7","key":"10.1016\/j.ncl.2018.01.004_bib66","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11910-016-0668-z","article-title":"Muscle-specific receptor tyrosine kinase (MuSK) myasthenia gravis","volume":"16","author":"Hurst","year":"2016","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"8","key":"10.1016\/j.ncl.2018.01.004_bib67","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/jnnp.2004.052415","article-title":"The features of myasthenia gravis with autoantibodies to MuSK","volume":"76","author":"Lavrnic","year":"2005","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"9","key":"10.1016\/j.ncl.2018.01.004_bib68","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.clinph.2005.06.003","article-title":"MuSK-antibody positive myasthenia gravis: clinical and electrodiagnostic patterns","volume":"116","author":"Stickler","year":"2005","journal-title":"Clin Neurophysiol"},{"issue":"7","key":"10.1016\/j.ncl.2018.01.004_bib69","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0929-6646(08)60171-0","article-title":"Clinical characteristics of MuSK antibody-positive myasthenia gravis in Taiwan","volume":"107","author":"Huang","year":"2008","journal-title":"J\u00a0Formos Med Assoc"},{"issue":"11","key":"10.1016\/j.ncl.2018.01.004_bib70","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1212\/01.WNL.0000128042.28877.C3","article-title":"Low frequency of MuSK antibody in generalized seronegative myasthenia gravis among Chinese","volume":"62","author":"Yeh","year":"2004","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.ncl.2018.01.004_bib71","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1468-1331.2008.02176.x","article-title":"MuSK-positive myasthenia gravis is rare in the Polish population","volume":"15","author":"Kostera-Pruszczyk","year":"2008","journal-title":"Eur J Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2018.01.004_bib72","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1212\/01.wnl.0000339103.08830.86","article-title":"HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5","volume":"72","author":"Bartoccioni","year":"2009","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.ncl.2018.01.004_bib73","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.humimm.2013.08.271","article-title":"Association of HLA-DRB1*14, -DRB1 *16 and -DQB1 *05 with MuSK-myasthenia gravis in patients from Turkey","volume":"74","author":"Alahgholi-Hajibehzad","year":"2013","journal-title":"Hum Immunol"},{"key":"10.1016\/j.ncl.2018.01.004_bib74","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jns.2016.02.031","article-title":"HLA-DRB1*14 and DQB1*05 are associated with Japanese anti-MuSK antibody-positive myasthenia gravis patients","volume":"363","author":"Kanai","year":"2016","journal-title":"J\u00a0Neurol Sci"},{"issue":"19","key":"10.1016\/j.ncl.2018.01.004_bib75","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.2169\/internalmedicine.54.4645","article-title":"Anti-MuSK antibody-positive myasthenia gravis mimicking amyotrophic lateral sclerosis","volume":"54","author":"Furuta","year":"2015","journal-title":"Intern Med"},{"issue":"6","key":"10.1016\/j.ncl.2018.01.004_bib76","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/jnnp.2009.171793","article-title":"Is tongue atrophy reversible in anti-MuSK myasthenia gravis? Six-year observation","volume":"81","author":"Takahashi","year":"2010","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.ncl.2018.01.004_bib77","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s12031-013-0170-x","article-title":"Collagen Q is a key player for developing rational therapy for congenital myasthenia and for dissecting the mechanisms of anti-MuSK myasthenia gravis","volume":"53","author":"Ohno","year":"2014","journal-title":"J\u00a0Mol Neurosci"},{"issue":"3","key":"10.1016\/j.ncl.2018.01.004_bib78","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/mus.21533","article-title":"Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience","volume":"41","author":"Pasnoor","year":"2010","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.ncl.2018.01.004_bib79","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/mus.20515","article-title":"Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody","volume":"34","author":"Punga","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2018.01.004_bib80","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1196\/annals.1405.012","article-title":"Response to therapy in myasthenia gravis with anti-MuSK antibodies","volume":"1132","author":"Evoli","year":"2008","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.ncl.2018.01.004_bib81","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ncl.2018.01.004_bib82","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1001\/archneur.62.6.1002","article-title":"Anti-MuSK myasthenia gravis presenting with purely ocular findings","volume":"62","author":"Caress","year":"2005","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2018.01.004_bib83","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1055\/s-2005-858629","article-title":"Ocular involvement in MuSK antibody-positive myasthenia gravis","volume":"223","author":"Bau","year":"2006","journal-title":"Klin Monbl Augenheilkd"},{"issue":"4","key":"10.1016\/j.ncl.2018.01.004_bib84","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/jnnp.2005.075812","article-title":"Anti-MuSK antibodies in a case of ocular myasthenia gravis","volume":"77","author":"Bennett","year":"2006","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.ncl.2018.01.004_bib85","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/bjo.2006.108498","article-title":"Ocular myasthenia: a rare presentation with MuSK antibody and bilateral extraocular muscle atrophy","volume":"91","author":"Chan","year":"2007","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ncl.2018.01.004_bib86","first-page":"659","article-title":"MuSK-antibody positive pure ocular myasthenia gravis","volume":"253","author":"Hanisch","year":"2006","journal-title":"J\u00a0Neurol"},{"issue":"21","key":"10.1016\/j.ncl.2018.01.004_bib87","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.2169\/internalmedicine.51.8196","article-title":"An ocular form of myasthenia gravis with a high titer of anti-MuSK antibodies during a long-term follow-up","volume":"51","author":"Hosaka","year":"2012","journal-title":"Intern Med"},{"issue":"7","key":"10.1016\/j.ncl.2018.01.004_bib88","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.nmd.2007.03.007","article-title":"Musk-antibody positive myasthenia gravis presenting with isolated neck extensor weakness","volume":"17","author":"Casasnovas","year":"2007","journal-title":"Neuromuscul Disord"},{"issue":"7","key":"10.1016\/j.ncl.2018.01.004_bib89","first-page":"496","article-title":"A\u00a0case of anti-MuSK antibody-positive myasthenia gravis with dropped head as the initial presenting symptom","volume":"46","author":"Okano","year":"2006","journal-title":"Rinsho Shinkeigaku"},{"issue":"2","key":"10.1016\/j.ncl.2018.01.004_bib90","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.nmd.2007.09.007","article-title":"Dropped head syndrome as prominent clinical feature in MuSK-positive Myasthenia Gravis with thymus hyperplasia","volume":"18","author":"Spengos","year":"2008","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"10.1016\/j.ncl.2018.01.004_bib91","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/mus.24687","article-title":"A\u00a0severe congenital myasthenic syndrome with \u201cdropped head\u201d caused by novel MUSK mutations","volume":"52","author":"Giarrana","year":"2015","journal-title":"Muscle Nerve"},{"issue":"8","key":"10.1016\/j.ncl.2018.01.004_bib92","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1212\/01.wnl.0000254617.15644.f4","article-title":"Vocal cord paralysis in myasthenia gravis with anti-MuSK antibodies","volume":"68","author":"Hara","year":"2007","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ncl.2018.01.004_bib93","first-page":"253","article-title":"Vocal cord paralysis as a manifestation of myasthenia gravis with anti-MuSK antibodies","volume":"29","author":"Jimenez Caballero","year":"2014","journal-title":"Neurologia"},{"issue":"9","key":"10.1016\/j.ncl.2018.01.004_bib94","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1136\/jnnp.2007.135319","article-title":"Dyspnoea due to vocal fold abduction paresis in anti-MuSK myasthenia gravis","volume":"79","author":"Sylva","year":"2008","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.ncl.2018.01.004_bib95","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/mus.23645","article-title":"Double-seropositive myasthenia gravis","volume":"47","author":"Zouvelou","year":"2013","journal-title":"Muscle Nerve"},{"issue":"1\u20132","key":"10.1016\/j.ncl.2018.01.004_bib96","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jneuroim.2013.12.012","article-title":"AChR-myasthenia gravis switching to double-seropositive several years after the onset","volume":"267","author":"Zouvelou","year":"2014","journal-title":"J\u00a0Neuroimmunol"},{"issue":"6","key":"10.1016\/j.ncl.2018.01.004_bib97","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.clineuro.2011.12.044","article-title":"MuSK myasthenia gravis and Lambert-Eaton myasthenic syndrome in the same patient","volume":"114","author":"Basta","year":"2012","journal-title":"Clin Neurol Neurosurg"},{"issue":"7","key":"10.1016\/j.ncl.2018.01.004_bib98","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/ncpneuro0526","article-title":"Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome","volume":"3","author":"Diaz-Manera","year":"2007","journal-title":"Nat Clin Pract Neurol"},{"issue":"3","key":"10.1016\/j.ncl.2018.01.004_bib99","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1212\/01.wnl.0000228225.23349.5d","article-title":"Anti-MuSK antibodies: correlation with myasthenia gravis severity","volume":"67","author":"Bartoccioni","year":"2006","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ncl.2018.01.004_bib100","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.nmd.2008.03.006","article-title":"Severe neonatal myasthenia due to maternal anti-MuSK antibodies","volume":"18","author":"Behin","year":"2008","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.1016\/j.ncl.2018.01.004_bib101","doi-asserted-by":"crossref","first-page":"188","DOI":"10.5692\/clinicalneurol.51.188","article-title":"A\u00a0pregnant patient with anti-MuSK antibody positive myasthenia gravis and her infant with transient neonatal myasthenia gravis","volume":"51","author":"Kanzaki","year":"2011","journal-title":"Rinsho Shinkeigaku"},{"issue":"2","key":"10.1016\/j.ncl.2018.01.004_bib102","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/CND.0b013e3181f8a9aa","article-title":"Transmission of maternal muscle-specific tyrosine kinase (MuSK) to offspring: report of two cases","volume":"12","author":"Murray","year":"2010","journal-title":"J\u00a0Clin Neuromuscul Dis"},{"issue":"14","key":"10.1016\/j.ncl.2018.01.004_bib103","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1212\/01.wnl.0000307751.20968.f1","article-title":"A\u00a0transient neonatal myasthenic syndrome with anti-musk antibodies","volume":"70","author":"Niks","year":"2008","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ncl.2018.01.004_bib104","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/CND.0b013e3181a78280","article-title":"Transient neonatal myasthenia gravis in a baby born to a mother with new-onset anti-MuSK-mediated myasthenia gravis","volume":"11","author":"O'Carroll","year":"2009","journal-title":"J\u00a0Clin Neuromuscul Dis"},{"issue":"5","key":"10.1016\/j.ncl.2018.01.004_bib105","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/WCO.0b013e32833c0982","article-title":"Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis","volume":"23","author":"Guptill","year":"2010","journal-title":"Curr Opin Neurol"},{"issue":"5","key":"10.1016\/j.ncl.2018.01.004_bib106","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1212\/WNL.65.5.782","article-title":"Thymus changes in anti-MuSK-positive and -negative myasthenia gravis","volume":"65","author":"Saka","year":"2005","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ncl.2018.01.004_bib107","doi-asserted-by":"crossref","first-page":"372","DOI":"10.5692\/clinicalneurol.53.372","article-title":"A\u00a0case of thymoma-associated myasthenia gravis with anti-MuSK antibodies","volume":"53","author":"Ito","year":"2013","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.ncl.2018.01.004_bib108","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jneuroim.2015.04.015","article-title":"MuSK autoantibodies in myasthenia gravis detected by cell based assay\u2013a multinational study","volume":"284","author":"Tsonis","year":"2015","journal-title":"J\u00a0Neuroimmunol"},{"issue":"3","key":"10.1016\/j.ncl.2018.01.004_bib109","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1212\/01.WNL.0000150587.71497.B6","article-title":"Thymus changes in anti-MuSK-positive and -negative myasthenia gravis","volume":"64","author":"Lauriola","year":"2005","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ncl.2018.01.004_bib110","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.20386","article-title":"Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG","volume":"57","author":"Leite","year":"2005","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2018.01.004_bib111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/14712590802588831","article-title":"A\u00a0comparison of long-term post-thymectomy outcome of anti-AChR-positive, anti-AChR-negative and anti-MuSK-positive patients with non-thymomatous myasthenia gravis","volume":"9","author":"Ponseti","year":"2009","journal-title":"Expert Opin Biol Ther"},{"issue":"10","key":"10.1016\/j.ncl.2018.01.004_bib112","first-page":"1780","article-title":"Juvenile seropositive myasthenia gravis with anti-MuSK antibody after thymectomy","volume":"256","author":"Kostera-Pruszczyk","year":"2009","journal-title":"J\u00a0Neurol"},{"issue":"8","key":"10.1016\/j.ncl.2018.01.004_bib113","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1212\/01.wnl.0000267694.45244.f4","article-title":"Anti-musk antibody after thymectomy in a previously seropositive myasthenic child","volume":"69","author":"Saulat","year":"2007","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ncl.2018.01.004_bib114","first-page":"174","article-title":"Switch to double positive late onset MuSK myasthenia gravis following thymomectomy in paraneoplastic AChR antibody positive myasthenia gravis","volume":"263","author":"Jordan","year":"2016","journal-title":"J\u00a0Neurol"},{"issue":"12","key":"10.1016\/j.ncl.2018.01.004_bib115","first-page":"2736","article-title":"Clinically biphasic myasthenia gravis with both AChR and MuSK antibodies","volume":"259","author":"Rajakulendran","year":"2012","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ncl.2018.01.004_bib116","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3988\/jcn.2009.5.2.53","article-title":"Muscle-specific receptor tyrosine kinase antibody positive myasthenia gravis current status","volume":"5","author":"Oh","year":"2009","journal-title":"J\u00a0Clin Neurol"},{"issue":"4","key":"10.1016\/j.ncl.2018.01.004_bib117","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/mus.20498","article-title":"Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis","volume":"33","author":"Oh","year":"2006","journal-title":"Muscle Nerve"},{"issue":"11","key":"10.1016\/j.ncl.2018.01.004_bib118","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1179\/1743132814Y.0000000387","article-title":"Electrophysiological profile of the patients with MuSK positive myasthenia gravis","volume":"36","author":"Nikolic","year":"2014","journal-title":"Neurol Res"},{"issue":"2","key":"10.1016\/j.ncl.2018.01.004_bib119","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1600-0404.2006.00721.x","article-title":"Anti-MuSK-positive myasthenia gravis: neuromuscular transmission failure in facial and limb muscles","volume":"115","author":"Kuwabara","year":"2007","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"10.1016\/j.ncl.2018.01.004_bib120","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.clinph.2006.10.004","article-title":"Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies","volume":"118","author":"Farrugia","year":"2007","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.ncl.2018.01.004_bib121","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jocn.2015.08.041","article-title":"Myopathic changes detected by quantitative electromyography in patients with MuSK and AChR positive myasthenia gravis","volume":"27","author":"Nikolic","year":"2016","journal-title":"J\u00a0Clin Neurosci"},{"issue":"3","key":"10.1016\/j.ncl.2018.01.004_bib122","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s13760-014-0364-1","article-title":"Myopathy, muscle atrophy and tongue lipid composition in MuSK myasthenia gravis","volume":"115","author":"Nikolic","year":"2015","journal-title":"Acta Neurol Belg"},{"issue":"Pt 6","key":"10.1016\/j.ncl.2018.01.004_bib123","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/awl095","article-title":"MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis","volume":"129","author":"Farrugia","year":"2006","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.ncl.2018.01.004_bib124","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2169\/internalmedicine.44.671","article-title":"Myasthenia gravis with anti-MuSK antibody, showing progressive muscular atrophy without blepharoptosis","volume":"44","author":"Ishii","year":"2005","journal-title":"Intern Med"},{"issue":"9","key":"10.1016\/j.ncl.2018.01.004_bib125","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jocn.2011.01.010","article-title":"Muscle atrophy in muscle-specific tyrosine kinase (MuSK)-related myasthenia gravis","volume":"18","author":"Moon","year":"2011","journal-title":"J\u00a0Clin Neurosci"},{"issue":"5","key":"10.1016\/j.ncl.2018.01.004_bib126","first-page":"746","article-title":"Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies","volume":"258","author":"Cenacchi","year":"2011","journal-title":"J\u00a0Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2018.01.004_bib127","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2990.2008.00965.x","article-title":"Muscle histopathology in myasthenia gravis with antibodies against MuSK and AChR","volume":"35","author":"Martignago","year":"2009","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"3","key":"10.1016\/j.ncl.2018.01.004_bib128","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1552-6569.2009.00456.x","article-title":"MRI evidence of early muscle atrophy in MuSK positive myasthenia gravis","volume":"21","author":"Zouvelou","year":"2011","journal-title":"J\u00a0Neuroimaging"},{"key":"10.1016\/j.ncl.2018.01.004_bib129","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jns.2015.11.032","article-title":"Reversible tongue muscle atrophy accelerated by early initiation of immunotherapy in anti-MuSK myasthenia gravis: a case report","volume":"360","author":"Kitamura","year":"2016","journal-title":"J\u00a0Neurol Sci"},{"issue":"2","key":"10.1016\/j.ncl.2018.01.004_bib130","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.expneurol.2011.04.018","article-title":"Muscle-selective synaptic disassembly and reorganization in MuSK antibody positive MG mice","volume":"230","author":"Punga","year":"2011","journal-title":"Exp Neurol"},{"issue":"5","key":"10.1016\/j.ncl.2018.01.004_bib131","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1460-9568.2010.07569.x","article-title":"MuSK levels differ between adult skeletal muscles and influence postsynaptic plasticity","volume":"33","author":"Punga","year":"2011","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.ncl.2018.01.004_bib132","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jneuroim.2015.12.016","article-title":"Longitudinal epitope mapping in MuSK myasthenia gravis: implications for disease severity","volume":"291","author":"Huijbers","year":"2016","journal-title":"J\u00a0Neuroimmunol"},{"issue":"9","key":"10.1016\/j.ncl.2018.01.004_bib133","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.autrev.2013.03.005","article-title":"Mechanisms associated with the pathogenicity of antibodies against muscle-specific kinase in myasthenia gravis","volume":"12","author":"Mori","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"1\u20132","key":"10.1016\/j.ncl.2018.01.004_bib134","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jneuroim.2008.01.013","article-title":"Clinical fluctuations in MuSK myasthenia gravis are related to antigen-specific IgG4 instead of IgG1","volume":"195","author":"Niks","year":"2008","journal-title":"J\u00a0Neuroimmunol"},{"issue":"51","key":"10.1016\/j.ncl.2018.01.004_bib135","doi-asserted-by":"crossref","first-page":"20783","DOI":"10.1073\/pnas.1313944110","article-title":"MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4","volume":"110","author":"Huijbers","year":"2013","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"11","key":"10.1016\/j.ncl.2018.01.004_bib136","doi-asserted-by":"crossref","first-page":"e80695","DOI":"10.1371\/journal.pone.0080695","article-title":"MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters","volume":"8","author":"Koneczny","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ncl.2018.01.004_bib137","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1212\/01.wnl.0000183145.91579.74","article-title":"Nonresponsiveness to anticholinesterase agents in patients with MuSK-antibody-positive MG","volume":"65","author":"Hatanaka","year":"2005","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ncl.2018.01.004_bib138","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3988\/jcn.2014.10.2.119","article-title":"Clinical and electrophysiologic responses to acetylcholinesterase inhibitors in MuSK-antibody-positive myasthenia gravis: evidence for cholinergic neuromuscular hyperactivity","volume":"10","author":"Shin","year":"2014","journal-title":"J\u00a0Clin Neurol"},{"key":"10.1016\/j.ncl.2018.01.004_bib139","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1749-6632.2012.06808.x","article-title":"Pathogenic IgG4 subclass autoantibodies in MuSK myasthenia gravis","volume":"1275","author":"Plomp","year":"2012","journal-title":"Ann N Y Acad Sci"},{"issue":"1\u20132","key":"10.1016\/j.ncl.2018.01.004_bib140","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jneuroim.2012.02.010","article-title":"3,4-Diaminopyridine improves neuromuscular transmission in a MuSK antibody-induced mouse model of myasthenia gravis","volume":"245","author":"Mori","year":"2012","journal-title":"J\u00a0Neuroimmunol"},{"issue":"11","key":"10.1016\/j.ncl.2018.01.004_bib141","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1212\/WNL.0000000000002466","article-title":"3,4-Diaminopyridine may improve myasthenia gravis with MuSK antibodies","volume":"86","author":"Evoli","year":"2016","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.ncl.2018.01.004_bib142","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1113\/jphysiol.2013.251827","article-title":"Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody","volume":"591","author":"Morsch","year":"2013","journal-title":"J\u00a0Physiol"},{"issue":"4","key":"10.1016\/j.ncl.2018.01.004_bib143","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11940-014-0283-8","article-title":"Treatment of MuSK-associated myasthenia gravis","volume":"16","author":"El-Salem","year":"2014","journal-title":"Curr Treat Options Neurol"},{"issue":"8","key":"10.1016\/j.ncl.2018.01.004_bib144","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1212\/01.wnl.0000254620.45529.97","article-title":"Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis","volume":"68","author":"Deymeer","year":"2007","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ncl.2018.01.004_bib145","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mus.22006","article-title":"Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts","volume":"44","author":"Guptill","year":"2011","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.ncl.2018.01.004_bib146","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1600-0404.2007.00877.x","article-title":"Long-term effect of intravenous immunoglobulin on anti-MuSK antibody-positive myasthenia gravis","volume":"116","author":"Shibata-Hamaguchi","year":"2007","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"10.1016\/j.ncl.2018.01.004_bib147","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jns.2006.05.065","article-title":"High-dose intravenous immunoglobulin for the treatment of MuSK antibody-positive seronegative myasthenia gravis","volume":"247","author":"Takahashi","year":"2006","journal-title":"J\u00a0Neurol Sci"},{"issue":"3","key":"10.1016\/j.ncl.2018.01.004_bib148","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/mus.20411","article-title":"High-dose cyclophosphamide in refractory myasthenia gravis with MuSK antibodies","volume":"33","author":"Lin","year":"2006","journal-title":"Muscle Nerve"},{"issue":"7","key":"10.1016\/j.ncl.2018.01.004_bib149","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.nmd.2016.04.008","article-title":"Anti-MuSK myasthenia gravis with prolonged remission","volume":"26","author":"Bouwyn","year":"2016","journal-title":"Neuromuscul Disord"},{"issue":"12","key":"10.1016\/j.ncl.2018.01.004_bib150","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1172\/JCI66039","article-title":"Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis","volume":"123","author":"Shen","year":"2013","journal-title":"J\u00a0Clin Invest"},{"issue":"42","key":"10.1016\/j.ncl.2018.01.004_bib151","doi-asserted-by":"crossref","first-page":"13892","DOI":"10.1523\/JNEUROSCI.1733-14.2014","article-title":"LRP4 is critical for neuromuscular junction maintenance","volume":"34","author":"Barik","year":"2014","journal-title":"J\u00a0Neurosci"},{"issue":"7416","key":"10.1016\/j.ncl.2018.01.004_bib152","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nature11348","article-title":"Lrp4 is a retrograde signal for presynaptic differentiation at neuromuscular synapses","volume":"489","author":"Yumoto","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ncl.2018.01.004_bib153","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neuron.2012.04.033","article-title":"Distinct roles of muscle and motoneuron LRP4 in neuromuscular junction formation","volume":"75","author":"Wu","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.ncl.2018.01.004_bib154","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jaut.2013.12.004","article-title":"A\u00a0comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis","volume":"52","author":"Zisimopoulou","year":"2014","journal-title":"J\u00a0Autoimmun"},{"issue":"5","key":"10.1016\/j.ncl.2018.01.004_bib155","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/mus.25591","article-title":"Anti-LRP4 autoantibodies in Chinese patients with myasthenia gravis","volume":"56","author":"Li","year":"2017","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.ncl.2018.01.004_bib156","first-page":"1193","article-title":"Screening for lipoprotein receptor-related protein 4-, agrin-, and titin-antibodies and exploring the autoimmune spectrum in myasthenia gravis","volume":"264","author":"Cordts","year":"2017","journal-title":"J\u00a0Neurol"},{"issue":"22","key":"10.1016\/j.ncl.2018.01.004_bib157","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.2169\/internalmedicine.55.7030","article-title":"Double seronegative myasthenia gravis with anti-LRP4 antibodies presenting with dropped head and acute respiratory insufficiency","volume":"55","author":"Beck","year":"2016","journal-title":"Intern Med"},{"issue":"8","key":"10.1016\/j.ncl.2018.01.004_bib158","doi-asserted-by":"crossref","first-page":"e0135378","DOI":"10.1371\/journal.pone.0135378","article-title":"Flow cytofluorimetric analysis of anti-LRP4 (LDL receptor-related protein 4) autoantibodies in Italian patients with myasthenia gravis","volume":"10","author":"Marino","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ncl.2018.01.004_bib159","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/mus.25438","article-title":"Agrin and low-density lipoprotein-related receptor protein 4 antibodies in amyotrophic lateral sclerosis patients","volume":"55","author":"Rivner","year":"2017","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.ncl.2018.01.004_bib160","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/acn3.26","article-title":"LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients","volume":"1","author":"Tzartos","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.ncl.2018.01.004_bib161","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1749-6632.2012.06833.x","article-title":"The search for new antigenic targets in myasthenia gravis","volume":"1275","author":"Cossins","year":"2012","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"10.1016\/j.ncl.2018.01.004_bib162","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/jamaneurol.2016.2032","article-title":"Clinical characteristics of patients with double-seronegative myasthenia gravis and antibodies to cortactin","volume":"73","author":"Cortes-Vicente","year":"2016","journal-title":"JAMA Neurol"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861918300045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861918300045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T01:53:46Z","timestamp":1660874026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861918300045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":162,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0733861918300045"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2018.01.004","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2018.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}